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Order and disorder—An integrative structure of the  
full-length human growth hormone receptor
Noah Kassem1†, Raul Araya-Secchi2†, Katrine Bugge1, Abigail Barclay2, Helena Steinocher1, 
Adree Khondker3, Yong Wang1, Aneta J. Lenard1, Jochen Bürck4, Cagla Sahin5, Anne S. Ulrich4, 
Michael Landreh5, Martin Cramer Pedersen2, Maikel C. Rheinstädter3, Per Amstrup Pedersen6, 
Kresten Lindorff-Larsen1*, Lise Arleth2*, Birthe B. Kragelund1*
Because of its small size (70 kilodalton) and large content of structural disorder (>50%), the human growth hor-
mone receptor (hGHR) falls between the cracks of conventional high-resolution structural biology methods. Here, 
we study the structure of the full-length hGHR in nanodiscs with small-angle x-ray scattering (SAXS) as the foun-
dation. We develop an approach that combines SAXS, x-ray diffraction, and NMR spectroscopy data obtained on 
individual domains and integrate these through molecular dynamics simulations to interpret SAXS data on the 
full-length hGHR in nanodiscs. The hGHR domains reorient freely, resulting in a broad structural ensemble, em-
phasizing the need to take an ensemble view on signaling of relevance to disease states. The structure provides 
the first experimental model of any full-length cytokine receptor in a lipid membrane and exemplifies how inte-
grating experimental data from several techniques computationally may access structures of membrane proteins 
with long, disordered regions, a widespread phenomenon in biology.
INTRODUCTION
The human growth hormone receptor (hGHR) is ubiquitously 
expressed and is activated by human growth hormone (hGH), pro-
duced in the pituitary gland. hGHR is important for regulating 
growth at a cellular and systemic level (1, 2) and is involved in the 
regulation of hepatic metabolism, cardiac function, bone turnover, 
and the immune system (3). Besides direct promotion of growth, its 
ligand hGH can also indirectly regulate growth by initiating the 
synthesis of insulin-like growth factor-I, an important factor in 
postnatal growth (4). Excess hGH production and mutations in the 
hGHR gene manifest in different diseases including cancer (5) and 
growth deficiencies (6), with associated cardiovascular, metabolic, 
and respiratory difficulties, and both hGH-based agonists and an-
tagonists of the receptor exist as approved drugs (7).
The hGHR is 1 of ~40 receptors belonging to the class 1 cytokine 
receptor family. The family is topologically similar with a tripartite 
structure consisting of a folded extracellular domain (ECD), a single- 
pass transmembrane domain (TMD), and a disordered intracellular 
domain (ICD) (8, 9). A characteristic trait of these receptors is the 
lack of intrinsic kinase activity, with the ICD, instead, forming a 
binding platform for a variety of signaling kinases and regulatory 
proteins (8, 10), as well as of certain membrane lipids (Fig. 1A) (9). 
Within the ECD, the receptors share a characteristic cytokine re-
ceptor homology domain consisting of two fibronectin type III 
domains (D1, N-terminal and D2, C-terminal), each with a 
seven-stranded -sandwich structure. Two hallmark disulfide bonds 
and a conserved WSXWS motif (X is any amino acid) (11) located 
in D1 and D2, respectively, are suggested to be important for cell 
surface localization and discrimination between signaling pathways 
(11, 12). In hGHR, this motif is instead YGEFS (10), but the reason 
for this variation has remained enigmatic. Besides hGHR, group 1 
of the class 1 cytokine receptors also encompasses the prolactin re-
ceptor (PRLR) and the erythropoietin (EPO) receptor. The group is 
considered to be the most structurally simple with one cytokine re-
ceptor homology domain and ligand binding in a homodimeric 2:1 
complex (10).
Receptor activation is achieved by hGH binding to hGHR via 
two asymmetric binding sites, leading to structural rearrangements 
that are propagated through the TMD to the ICD. A recent study 
found that when hGH binds to a preformed hGHR dimer, structur-
al rearrangements in the ECD leads to separation of the ICDs 
just below the TMD (13). This leads to activation through cross- 
phosphorylation of the Janus kinases 2 (JAK2) bound at the proline- 
rich Box1 motif in the juxtamembrane region (13). Furthermore, 
this study demonstrated that receptor dimerization in isolation is 
insufficient for receptor activation (13). Nonetheless, while recent 
single-particle tracking studies suggested dimerization to depend 
on expression levels (14), it is still debated to what extent the hGHR 
exists as preformed dimers in vivo (15) or whether the hGHR only 
dimerizes upon hGH binding.
From the viewpoint of structural biology, the hGH/hGHR sys-
tem has a high molecular complexity with ordered and disordered 
domains joined by a minimal membrane embedded part. Hence, struc-
tural characterization has, so far, been based on a divide-and-conquer 
approach, where the domains have been studied in isolation. This 
includes the crystal structures of the ECD in the monomeric state 
(15), in 1:1 (16) and 2:1 (17) complexes with hGH, and of hGH alone 
(18). Furthermore, structures of the dimeric state of the hGHR-
TMD in detergent micelles have been solved by nuclear magnetic 
resonance (NMR) (19) spectroscopy, while the hGHR-ICD was shown 
by NMR to adopt a fully intrinsically disordered region (IDR) (9). A re-
cent approach that combined experimental data with computational 
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efforts provided a model of the similar PRLR monomer built from 
integration of several individual sets of experimental data recorded 
on isolated domains (20). This work provided the view of a full-length 
class 1 cytokine receptor to scale. However, no structure or model 
based on data collected on an intact, full-length class I cytokine 
receptor exists, leaving a blind spot for how the domains affect each 
other and are spatially organized.
Even with advances in cryo–electron microscopy (EM), the full-
length hGHR remains a challenge to structural biology. With 70 kDa, 
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Fig. 1. The hGHR has a dynamic ECD with a broad structural ensemble. (A) A schematic representation of homodimeric hGHR (blue) in the membrane in complex with 
hGH (green). ECD, Extracellular domain; TMD, transmembrane domain; and ICD, intracellular domain. (B) SEC profiles of hGHR-ECD and hGH in 20 mM Na2HPO4/NaH2PO4 (pH 7.4) 
and 150 mM NaCl at ratios 1:0 (hGH:hGHRECD 1:0), 0:1 (hGH:hGHR-ECD 0:1), 1:2 (hGH:hGHR-ECD 1:2), and 4:1 (hGH:hGHR-ECD 4:1). Absorption was measured at 280 nm. 
(C) Concentration-normalized SAXS data from hGHR-ECD (concentrations in legend) with the p(r) from the sample (3.5 mg/ml) shown as inset. a.u., absorbance units. (D) SAXS 
data from hGHR-ECD at 3.5 mg/ml (black dots) together with fits of the theoretical scattering curves from a crystal structure of hGRH-ECD (blue; PDB 3HHR), the same crystal 
structure with missing loops completed (purple), and the average (green) and reweighted average [red; reweighted against the experimental data using the Bayesian maxi-
mum entropy approach (see Materials and Methods)] of scattering curves of the 500 hGHR-ECD models with added N- and C-terminal tails. Residuals are plotted below. (E) An 
ensemble model of the hGHR-ECD with a representative reweighted subensemble of 100 models highlighting the N-terminal (cyan) and C-terminal (green) dynamic tails.
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fact that more than 50% of the protein is intrinsically disordered 
leaves only ~30 kDa visible. Likewise, the disorder of the ICD also 
hampers crystallographic studies. On the other hand, a 70-kDa pro-
tein together with membrane mimetics make up a too large target 
for NMR, where the combined molecular properties would lead to 
slow tumbling and severe line broadening. Hence, the hGHR ap-
pears to be an orphan in structural biology, along with a large group 
of other membrane proteins with long, disordered regions, includ-
ing most of the ~1400 human single-pass membrane proteins (21).
Integrative structural modeling is a powerful approach to combine 
different sources of experimental information to study the structure 
and dynamics of biomolecules (22). Such approaches are particular-
ly suitable for large and dynamic molecules whose structure cannot 
be solved by traditional means. When experimental information 
comes from lower-resolution techniques, such as solution small-angle 
x-ray and neutron scattering (SAXS/SANS), it is often necessary to 
combine the experimental information with molecular simulations 
or other modeling techniques (22, 23). The best choice of experi-
ments and computational models depends on the system at hand, 
including its size and level of flexibility. For large and highly flexible 
systems, coarse-grained (CG) simulations provide a suitable balance 
between the ability to sample many different types of conformations 
and capturing key aspects of protein biophysics (23, 24). Recent 
advances building on the use of nanodiscs (25) have further proved 
its applicability in membrane protein structural biology when combined 
with computational modeling (26, 27). However, no membrane 
protein with the degree of disorder seen in hGHR has previously 
been studied in a nanodisc or approached by small-angle scattering.
Here, we applied an integrative approach to probe the structure 
of the monomeric hGHR from SAXS data recorded on the full-
length receptor in a nanodisc. The data were validated and inter-
preted by combining SAXS, NMR, and x-ray diffraction (XRD) data 
obtained on the individual domains of hGHR through computa-
tional modeling. This has resulted in an experimentally supported 
structure based on studies of an intact, full-length, single-pass cyto-
kine receptor in a lipid membrane, a topology that represents ~40 
human cytokine receptors and many other membrane proteins. 
Our approach exemplifies that combining SAXS and computation-
al modeling could be the bridge required for accessing structural 
information on the ~1400 single-pass receptors in humans (28).
RESULTS
To arrive at the final result of this work, we took on a three-step 
approach. First, to aid the analysis of SAXS data on the full-length 
hGHR and qualify the integrity of the methodology, several differ-
ent biophysical data were acquired and analyzed on isolated, indi-
vidual parts of the hGHR. Second, SAXS and SANS data were 
acquired on the full-length hGHR in nanodiscs, expressed in yeast 
cells and carrying a C-terminal green fluorescent protein (GFP)–
deca-histidine tag (GFP-H10). Last, all the data were interpreted and 
integrated using molecular dynamics (MD) simulations.
The binding-competent hGHR-ECD solution state ensemble 
contains disorder
While crystal structures of an N- and C-terminally truncated ver-
sion of the hGHR-ECD exist (16–18), the complete hGHR-ECD has 
not previously been studied in solution. Therefore, to describe the 
ensemble of the full domain, we purified hGHR-ECD (residues 1 to 
245, omitting the signal peptide) and hGH from expression in 
Escherichia coli. On the basis of circular dichroism (CD) data, the hGH 
was folded with the expected helicity (fig. S1A). The CD spectrum 
of hGHR-ECD had pronounced positive ellipticities around 230 nm 
stemming from aromatic exciton couplings, a trait of cytokine re-
ceptors, and showed additional contributions from disorder at 200 nm 
(fig. S1B). The functionality of the hGHR-ECD was confirmed from 
its ability to form complexes as determined by Kav for hGH and its 
1:1 and 1:2 complexes with hGHR-ECD from analytical size exclusion 
chromatography (SEC) (Fig. 1B and fig. S1, C and D). By varying 
the ratio of hGH to hGHR-ECD, we could isolate the 1:2 complex 
and the 1:1 complex (GH in four times excess) and obtain the mass 
of hGH, hGHR-ECD, and the 1:1 and 1:2 complexes using the for-
ward scattering from SAXS approximated through the derived 
pair-distance distribution functions, p(r)’s (table S1 and fig. S1, E to 
G). Thus, the structural and functional integrity of both renatured 
proteins were confirmed. Last, to understand the ensemble proper-
ties of the hGHR-ECD in solution and generate a model, we ac-
quired SAXS data on free hGHR-ECD at varying concentrations. 
The concentration-normalized SAXS data fully overlaid (Fig. 1C), 
showing no visible interaction effects. The derived p(r) (Fig. 1C, inset) 
was skewed with a broad maximum around 30 Å and a maximum 
length (Dmax) of ~100 Å, consistent with the hGHR-ECD having a 
nonglobular shape. Comparison of the SAXS data to a theoretical 
scattering profile obtained from one of the structures of hGHR-
ECD (PDB 3HHR) (17) resulted in a poor fit (Fig. 1D, blue). However, 
the absence of the N- (1 to 30) and C-terminal (231 to 245) tails and 
two disordered loops (57 to 61; 74 to 77) may account for this and 
highlights that these tails contribute importantly to the ensemble 
properties. We therefore built a model of the hGHR-ECD, where 
the missing loops were added. The calculated scattering profile of 
this model provided a slightly improved fit to the SAXS data, which 
further suggested that a substantial contribution to the scattering comes 
from the conformational heterogeneity of the N- and C-terminal 
tails. To address this issue, we built an ensemble of 5000 models of 
the full-length hGHR-ECD including the N- and C-terminal tails 
using the “Floppy tail” (29) protocol from Rosetta (30). An average 
of the theoretical scattering intensities from these models was fitted 
to the experimental SAXS data (Fig. 1D, green) with 2 of 34, about 
five times smaller than when using the crystal structure and a single 
conformation with completed flexible loops. Thus, an ensemble 
representation including the terminal tails provided a much better fit 
to the SAXS data. The ensemble was further refined by reweighting 
against the experimental data using the Bayesian maximum entropy 
(BME) approach (31), which brought 2 to 4.3 using effectively 27% 
of the models (Fig. 1D, red). The Rg distributions of the models be-
fore and after reweighting are shown in fig. S1H. A subensemble of 
500 conformations, representative of the reweighted ensemble, was 
generated. Although any of these conformations would be a good 
representative, we selected a single structure with an Rg most similar 
to the experimentally determined Rg for building the model of the 
full-length hGHR (see below). A total of 100 conformations of this 
subensemble are shown in Fig. 1E, illustrating how the disordered 
regions contribute to the space-filling properties of the hGHR-ECD.
The monomeric hGHR-TMD is organized parallel 
to the membrane normal
Structures of hGHR-TMD were recently solved in dimeric states 
(19) in micelles of the detergent d38-dodecylphosphocholine (DPC). 
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To describe the structure and the tilt angle of the monomeric hGHR- 
TMD relative to the membrane, we designed this domain of hGHR 
with six- and five-residue overlap with hGHR-ECD and hGHR-ICD, 
respectively. The resulting 36-residue hGHR-TMD (F239-R274), 
including an N-terminal Gly-Ser, was produced with and without 
isotope labeling by a fast-track production method for single-pass TMDs 
(32). Subsequently, the peptides were reconstituted in either lipid 
bilayers (see below) or 1,2-dihexanoyl-sn-glycero- 3-phosphocholine 
(DHPC) micelles, previously used successfully for structure determi-
nation of the closely related hPRLR-TMD (20).
A schematic overview of the extent of the hGHR-TMD  helix 
determined by NMR spectroscopy or bioinformatics is shown in 
Fig. 2A. To compare the structural characteristics of this hGHR-TMD 
with the previously published structures (19), we analyzed isotope- 
labeled hGHR-TMD in DHPC micelles by NMR and CD spectros-
copy (Fig. 2B and fig. S2, A and B). From motif identification from 
chemical shifts (MICS) analysis (33) of NMR backbone chemical 
shifts and from backbone amide R2 relaxation measurements, we 
observed that the hGHR-TMD populated a fully formed  helix in 
DHPC micelles from W249-K271 (Fig.  2B). This agrees with the 
findings for hGHR-TMD dimers in DPC micelles (19), suggesting 
the length of the TMD  helix to be maintained across different 
membrane mimetics. For building the full-length hGHR model (see 
below), we used the backbone chemical shift–derived dihedral 
angles (from TALOS) or the chemical shifts directly to calculate a 
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Fig. 2. The single-pass -helical hGHR-TMD. (A) Extent of the hGHR-TMD  helix by NMR (black), TMHMM (blue), Phobius (red), METSAT-SVM (purple), and UniProt 
(green) (fig. S2). Cylinder represents length of the hGHR-TMD  helix by NMR with the first and last helical residue numbered. (Left) Predicted numbers. (B) MICS  helix 
probability (top) and R2 relaxation rates (bottom) of hGHR-TMD in DHPC micelles. Red diamonds, insufficient data quality or prolines. (C) Models of hGHR-TMD  helix by 
CYANA (blue) or CS-Rosetta (magenta). (D) Energy versus C-RMSD from CS-Rosetta modeling of hGHR-TMD. (E) Electron density profiles (EDPs) of lipid bilayers [POP-
C:POPS 3:1 mole percent (mol %)] with hGHR-TMD at 0.2 and 2 mol %, respectively. (F) Difference EDPs and best-fit profiles for the hGHR-TMD CS-Rosetta and the CYANA 
models, respectively. (G) Hermans orientation (left) and Lamellar spacing (right) of membranes at varying concentrations of hGHR-TMD. *, onefold change; ***, threefold change. 
(H) Illustration of membrane curvature. (I) Top: Oriented CD (OCD) spectra of 6 g of hGHR-TMD in POPC, with L:P ratios varied from 1:40 to 1:200. Bottom: OCD spectra 
of 6 g of hGHR-TMD in POPC, POPC:POPS (3:1), or DOPC at an L:P ratio of 50:1. The dashed lines represent nonreliable data due to too high high-tension voltage values.
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CS-Rosetta (35), respectively. The helix covered W249-K271  in 
both structures, which aligned with a root mean square deviation 
(RMSD) of the Cs of 0.78 Å (Fig. 2, C and D).
To support the modeling, we reconstituted the hGHR-TMD in a 
more native-like membrane system of stacked bilayers. We used 
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC):1- 
palmitoyl-2-oleoyl-sn-glycero-3-phospho-l-serine (POPS) (3:1 
molar ratio) and investigated structures and tilt angles by XRD, tak-
ing advantage of the oligomeric state of single-pass TMDs that may 
be manipulated through the detergent-to-protein or lipid-to-protein 
(L:P) ratio (19). The measured reflectivity Bragg peaks allowed us to 
determine the electron density profiles (EDPs), (z), of the different 
bilayer structures (Fig. 2E) and EDP difference plots, (z) (Fig. 2F), 
of the membranes with and without inserted hGHR-TMD helices at 
varying molar ratios. The EDPs contain information about the po-
sition in the membrane and tilt angle. The EDPs of the helices were 
calculated for the monomer based on the CS-Rosetta and CYANA 
structures, respectively, and for the dimer based on a previously de-
termined NMR structure [PDB 5OEK (19)]. This was done for dif-
ferent tilt angles and fitted to the experimental densities (36).
Our XRD analysis showed that at monomer conditions for the 
hGHR-TMD (high L:P ratio of 500:1; Fig.  2F, top), the helix re-
mained parallel to the membrane normal (tilt angle of 19° ± 10°) 
without effects on membrane thickness, dz. The discrepancy be-
tween fit and experimental data at z values of ~18 Å (in the head 
group region of the membranes) for the CYANA model in 0.2 mole 
percent (mol %) results from the fact that the CYANA model in-
cludes the unstructured tail (which is not part of the Rosetta model). 
This tail partitions into the water phase and is not well picked up in 
the EDP structure. Within the membrane bilayer, the fitting to the 
CYANA model was, therefore, slightly better. At dimer conditions 
(low L:P ratio of 50:1), we found that the helix tilt angle changed to 
45° ± 10° relative to the membrane normal, in accordance with the 
hGHR-TMD dimer structures (Fig. 2F, bottom) (19). While the mem-
brane flatness and intactness, as measured by Hermans orientation 
function H, was unaffected by the presence of monomers or dimers 
(Fig. 2G, left), the dimer induced some membrane compression, giving 
rise to a slightly thinner bilayer with smaller laminar spacing, dz 
(Fig. 2G, right). An illustration of this behavior is shown in Fig. 2H.
To support these observations, we used oriented CD (OCD) 
spectroscopy with reconstitution of the hGHR-TMD in POPC, 
POPC:POPS (3:1), or 1,2-dioleoyl-sn-glycero-3-phosphocholine 
(DOPC) multilamellar bilayers (Fig. 2I and fig. S2C). In OCD, the 
ellipticity of the negative band at 208 nm, which is parallelly polar-
ized to the helix axis, is strongly dependent on helix orientation, 
allowing distinction between a fully inserted state (I state, parallel to 
membrane normal), a tilted state (T state), and a surface-bound 
state (S state, perpendicular to the membrane normal). At dimer 
conditions (L:P ratio of 50:1), the OCD spectra showed two nega-
tive bands at 208 and 222 nm and a positive band at 190 nm in all 
types of membranes tested (Fig. 2I), indicating successful reconsti-
tution with formation of helical structure. Furthermore, the nega-
tive ellipticity at 208 nm was smaller compared to that at 222 nm, 
demonstrating the hGHR-TMD to be either in a T state or in an 
equilibrium between an S state and an I state (37). Increasing the 
L:P ratio decreased the negative band intensity at 208 nm, which 
even became positive at an L:P ratio of 200:1 (Fig. 2I, top). This in-
dicated that at monomer conditions, the hGHR-TMD populated 
the more parallel I state, fully supporting the results from XRD.
A C-terminal GFP has no influence on the ICD ensemble
For purification of the full-length hGHR, a C-terminal GFP-H10-tag 
had to be included (21). To ensure that this did not introduce intra- 
or intermolecular interactions interfering with the hGHR-ICD 
ensemble, we produced the hGHR-ICD (S270-P620) without and 
with GFP-H10 (hGHR-ICD-GFP-H10). The 15N–heteronuclear 
single-quantum coherence (HSQC) spectra of these two proteins were 
almost identical (Fig. 3A), confirming an unperturbed ICD ensem-
ble. We also compared SAXS data acquired on both, which revealed 
a large increase in the forward scattering in the presence of GFP 
(Fig. 3B), reflecting the increase of the molar mass from 38.6 kDa 
for hGHR-ICD to 68.0 kDa for hGHR-ICD-GFP-H10 (table S1). 
The derived p(r) functions (Fig.  3D) showed not only an in-
creased probability of short distances because of the folded GFP but 
also a conserved Dmax consistent with an overall unaffected ICD coil 
conformation. The addition of GFP did not give rise to a significant 
change in Rg (65 Å for both) (Fig. 3B), whereas the hydrodynamic 
radius (Rh) obtained by NMR spectroscopy increased from 44 to 
51 Å (Fig. 3C). We note that Rg/Rh of ~1.5 for the hGHR-ICD falls 
in the range typically observed for linear chains in random coil con-
formations, while the smaller ratio obtained for the hGHR-ICD-
GFP-H10 is consistent with the hGHR-ICD-GFP-H10 containing a 
larger fraction of folded protein. Together, these results indicate that 
the C-terminal addition of GFP-H10 did not change the structural 
ensemble of hGHR-ICD.
Scaling of the protein-water interactions is required 
to simulate the ensemble properties of hGHR-ICD
To aid in interpretation of the data of the full-length hGHR, the 
ensemble properties of the hGHR-ICD were modeled on the basis 
of the SAXS data following two approaches: (i) through fitting of 
the data by the form factor for simple (non–self-avoiding) Gaussian 
random coils (38) and (ii) using CG-MD simulations adapted to 
better represent the dynamics of intrinsically disordered proteins 
(IDPs), providing an ensemble that better describes the experimen-
tal data. Approach (i) provided an excellent fit to the full experi-
mental SAXS q range, yielding an Rg of 68 ± 4 Å (Fig. 3B, orange) 
with a 2 of 1.4. This showed the average conformation of the 
hGHR-ICD to be very well described by a simple random coil model, 
which implicitly assumes a scaling exponent,  = 0.5. We also 
obtained similar Rg values (~65 Å) from fits using different scaling 
exponents (0.588 to 0.602) empirically predicted for unfolded pro-
teins or IDPs or derived from computational analyses (table S2). 
Hence, the values agree closely, and the effect of assuming a simple 
idealized Gaussian random coil model has a negligible effect on the 
resulting Rg.
Protein-protein interactions may be overestimated in the Martini 
force field translating into unrealistic compaction of disordered re-
gions and inability to reproduce experimentally obtained values for 
Rg or Rh (24). Recent reports investigating two multidomain pro-
teins connected by flexible linkers suggested that this could be over-
come by increasing the strength of protein-water interactions (24). 
In the case of hGHR with a long, disordered ICD, we performed 
unbiased and enhanced sampling metadynamics simulations using 
the Martini 3 force field modified by increasing the strength of the 
protein-water interactions in the range of 5 to 15%. Our goal was to 
search for a value that could provide an optimized description of 
the ensemble of GHR-ICD. Back-mapped atomistic conformations 
from these simulations were used to calculate their average Rg and 
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to obtain theoretical scattering intensities, which were then fitted to 
the SAXS data of hGHR-ICD (fig. S3). Our results indicate that an 
increase in the protein-water interaction strength of 10% produced 
optimal results (Fig. 3B and fig. S3). Thus, we settled on rescaling 
the protein-water interaction by 10% to obtain a reliable conforma-
tional ensemble of the hGHR-ICD and to be used in the simulation 
of the full-length hGHR-GFP system. We note that although lowly 
populated (<20%) transient helices were previously observed from 
NMR secondary chemical shifts (9), these are not to be captured by 
the CG simulations or the SAXS data.
Full-length hGHR reconstituted in nanodiscs forms 
monomers and dimers
The intact hGHR tagged with GFP-His10 (hGHR-GFP) was expressed in 
the Saccharomyces cerevisiae strain PAP1500, purified, and reconsti-
tuted into POPC-loaded membrane scaffold protein 1D1 (MSP1D1) 
nanodiscs as described in Kassem et al. (21). Although an NMR solution 
structure of the MSP1D1H5 exists based on their reconstitution with a 
1,2-dimyristoyl- sn-glycero-3-phosphocholine bilayer (39), we used the 
MSP1D1 nanodisc and POPC, as this combination is currently the 
most-applied and best-characterized carrier system by SAXS and SANS 
(40–42), making experimental handling and subsequent computation 
of the nanodisc- embedded full-length structure of hGHR more reli-
able. In SEC, the hGHR-GFP in MSP1D1 eluted over a broad peak 
from 10 to 14 ml (Fig. 4A). This suggested that the hGHR-GFP was re-
constituted in the discs potentially as both monomers and dimers or as 
higher-order oligomers. To quantify the number of hGHR-GFP per 
disc, we performed an SDS–polyacrylamide gel electrophoresis (PAGE) 
analysis of hGHR-GFP and MSP1D1 standards along with hGHR- 
loaded MSP1D1 discs isolated from the SEC at different elution volumes 
(Fig. 4B). From gel quantifications of hGHR-GFP and MSP1D1, 
we found the ratio over the peak to vary from ~2 hGHR-GFP per disc 
(F1) to ~1 hGHR- GFP per disc (F3). Since reconstitution was con-
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Fig. 3. Properties of the hGHR-ICD ensemble. (A) 1H-15N-HSQC spectra at 5°C of hGHR-ICD (black) and hGHR-ICD-GFP-H10 (red) at 150 and 100 M, respectively. 
(B) Concentration normalized SAXS data from hGHR-ICD (black dots; 1.1 mg/ml) and hGHR-ICD-GFP-H10 (red dots; 2.2 mg/ml). Fits to the data are shown for a Gaussian 
random coil model (orange) and from averaged scattering profiles from 5200 conformations taken from the hGHR-ICDub_pws10 simulation (one every nanosecond) (blue). 
Residuals are plotted below. (C) RH of hGHR-ICD and hGHR-ICD-GFP-H10 determined from pulse-field gradient NMR. Signal decays of hGHR-ICD (black) and hGHR-ICD-
GFP-H10 (red) are shown as a function of gradient strength together with the corresponding fits. (D) Concentration normalized p(r)’s derived from the above SAXS data 
from hGHR-ICD (black) and hGHR-ICD-GFP-H10 (red). A subensemble of 200 conformations representative of the hGHR-ICDmetaD_pws10 simulation is shown in the right side 
of the plot.
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probability of capturing more than one hGHR-GFP per disc, we argue 
that the distribution across the peak likely represents the equilibrium be-
tween dimeric and monomeric hGHR-GFP. These results also sug-
gested that the hGHR-GFP can form dimers in the absence of hGH as 
previously suggested (13), most likely through the TMD region (13, 15).
The number of lipids in the hGHR-loaded MSP1D1 nanodiscs 
is as expected
We used phosphorus analysis (43) performed on samples across the 
SEC peak (fig. S4A) to quantify the number of POPC lipids in the 
hGHR nanodiscs. In the fractions with dimers (F1), the ratio be-
tween MSP1D1 nanodiscs and POPC was 115 ± 19, and in the frac-
tion with monomers (F3), it was 122 ± 17. The SD is based on two 
repetitive measurements each on two separate samples. This is 
comparable to results obtained in other studies of POPC nanodiscs 
with an -helical membrane-anchored protein (27) and in good 
agreement with the values obtained for nanodiscs solely filled with 
POPC [~110 to 130 POPC per nanodisc (41)]. The number of lipids 
was used as input for the modeling of the SAXS data of hGHR-
GFP- containing MSP1D1 nanodisc.
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Fig. 4. Incorporation of hGHR-GFP into MSP1D1, functional, and structural analysis. (A) SEC profile of hGHR-GFP-loaded MSP1D1. The areas highlighted in gray indicate 
fractions (F1 to F3) used for the SDS-PAGE analysis in (B). (B) SDS-PAGE analysis of hGHR-GFP and MSP1D1 standards along with hGHR-GFP-loaded MSP1D1. Fractions F1 to F3 
were taken from the indicated positions of the SEC-purified hGHR-GFP-loaded MSP1D1 shown in (A). The illustration above the gel shows the stoichiometry of the hGHR-GFP-
loaded MSP1D1. (C) Intact mass spectra of hGHR-GFP show a single protein population with an average mass of 100,951 ± 64 Da. Asterisks denote detergent peaks. (D) MST determi-
nation of equilibrium binding constants for hGH to hGHR-GFP-loaded MSP1D1. The mean values and SD were obtained by fitting a 1:1 binding model (full line) as described in 
Materials and Methods. Concentration-normalized (E) SAXS data and (F) SANS data of the nanodisc-embedded hGHR-GFP corresponding to the highlighted SEC frames in 
fig. S4 (C and D).
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hGHR retains its signal peptide but is not N-glycosylated 
when produced in yeast
The hGHR has five confirmed N-glycosylation sites at N28, N97, 
N138, N143, and N282 (44), whereas it is unknown if it is O-glycosylated. 
To assess whether the recombinant hGHR-GFP from S. cerevisiae 
was N-glycosylated, the electrophoretic mobility before and after 
treatment with endoglycosidase H was evaluated (fig. S4B). No 
mobility change was observed, and the band sharpness was equally 
high before and after treatment, suggesting the lack of N-glycosylations. 
This is in line with previous observations on other human mem-
brane proteins produced in the same yeast expression system (45). 
To determine whether yeast-produced hGHR-GFP was O-glycosylated, 
we performed Western blot with horseradish peroxidase conju-
gated with concanavalin A, which binds to mannose residues in 
O-glycosylated proteins (45). A faint band corresponding to hGHR-
GFP was seen, indicating minor O-glycosylation (fig. S4B). As a 
negative control, MSP1D1 purified from E. coli was not detected 
(fig. S4B). As a final control, we recorded native mass spectrometry 
(MS) on the purified, full-length hGHR-GFP in detergent, before 
reconstitution into nanodiscs. No glycosylation was detected. Instead, 
as expected from the cellular localization (21), the hGHR-GFP 
maintained its signal peptide (SP) (expected mass of 100,850.44 Da; 
the small deviation in mass caused by Na+ adducts) (Fig. 4C).
Recombinant full-length hGHR-GFP reconstituted 
in nanodiscs is fully binding competent
To ensure that full-length hGHR-GFP embedded in the MSP1D1 
nanodisc was functional, we measured equilibrium binding con-
stants for the interaction between hGH and hGHR-GFP(MSP1D1) 
by microscale thermophoresis (MST). In these studies, a 20 nM 
solution of fluorescently labeled (NT-647-NHS) hGH was incubated 
with increasing concentrations of hGHR-GFP(MSP1D1) (23 pM to 
750 nM) using unlabeled hGH as the control. With this approach, 
the dissociation constant between hGH and hGHR-GFP(MSP1D1) 
was determined to be Kd = 5 ± 2 nM (Fig. 4D). As another control, 
we previously showed that hGHR(MSP1D1) is unable to bind hu-
man prolactin (21), which cannot activate hGHR in vivo (46). The 
affinities of hGH for hGHR-ECD have previously been reported as 
1.2 and 3.5 nM for the first and the second site of hGH, respectively 
(47). Taking all this into consideration, we find that our data 
agree well with previous findings and conclude that the nanodisc- 
reconstituted, yeast-produced full-length hGHR-GFP is fully bind-
ing competent.
SEC-SAXS and SEC-SANS data of the full-length hGHR-GFP 
in nanodiscs
We obtained structural data of the reconstituted full-length hGHR-GFP 
in a POPC-loaded MSP1D1 nanodisc from SEC-SAXS (Fig. 4E and 
fig. S4C) and SEC-SANS (Fig. 4F and fig. S4D) with p(r) functions 
in insets of Fig. 4 (E and F). As was the case for the initial analysis, 
the SEC profiles from both SEC-SAXS and SEC-SANS (fig. S4, C and D) 
were relatively broad and consistent with the underlying heterogeneity 
and systematic decrease of the particle size. Analysis of the data ob-
tained over the SEC-SAXS and SEC-SANS elution peaks confirmed 
this picture, and SEC-SAXS showed Rg decreasing from 120 to ~75 Å 
over the frames from 10 to 14 ml (fig. S4C). The SEC-SANS–
derived Rg also decreased steadily over the frames from 10 to 14 ml 
(fig. S4D) but were consistently ~10 Å smaller than in the SAXS 
experiment. The different Rg values for SAXS and SANS are a 
consequence of the nonhomogeneous and rather different excess 
scattering length density distributions of the nanodisc-embedded 
hGHR-GFP for x-rays and neutrons. The decrease in both the Rg, 
the low q scattering intensity, and the development of the p(r)’s over 
the SEC peaks is fully consistent with the presence of discs containing 
the first two and then one hGHR-GFP, respectively, as also supported 
by our biochemical analysis (Fig. 4, A and B). In addition to dimeriza-
tion, the large Rg values obtained from the left side of the SEC peak 
could also arise from an overlap with the void volume (at 8 to 10 ml). 
We obtained a value of Dmax of ~200 to 250 Å from the SAXS data 
corresponding to discs with one hGHR. The low signal to noise at 
the right side of the SEC-SANS peak, corresponding to the mono-
meric fractions, did unfortunately not allow for a robust analysis of 
the SANS data. The dimeric fractions exhibited a significantly larger 
Dmax of ~350 Å in both SAXS and SANS. This larger size likely re-
sults from the larger extension of the two long uncorrelated ICDs. The 
shoulder around 0.1 Å−1 of the SAXS data (Fig. 4E) is a typical sig-
nature of the lipid bilayer from the embedding nanodiscs (26, 27, 48).
Below, we focus our analyses on the structure of monomeric 
hGHR-GFP. First, while we can build an initial model of a mono-
meric hGHR from the chain connectivity and structures of the ECD 
and TMD, building models of the hGHR dimer would require further 
assumptions on the dimerization interface. Second, experimental 
complications arise both from the potential overlap with the void 
volume in the SEC-SAXS/SANS experiments and from possible struc-
tural heterogeneity. This may originate not only from a dynamic 
monomer-dimer equilibrium but also from different dimers in the 
nanodisc: the biologically relevant down-down dimer conformation, 
a trapped up-down conformation, or higher-order structures. We 
therefore concentrated on the reliable SEC-SAXS data representing 
monomeric hGHR-GFP in a nanodisc and used these to obtain the 
monomeric full-length hGHR-GFP structure embedded in a nano-
disc bilayer.
The structure of the monomeric full-length hGHR-GFP 
in a nanodisc
We followed a three-stage approach to derive a model of the struc-
ture of monomeric hGHR including the signal peptide and the GFP 
(hereafter named the hGHR-GFP) in the MSP1D1 nanodisc. First, 
we built a semianalytical model of the nanodisc-embedded full-length 
hGHR-GFP to refine the nanodisc parameters and to validate the 
overall structure of the complex. Second, we generated an ensemble 
of 6000 structures of the hGHR-GFP embedded in a POPC bilayer 
from 20 2-s-long CG-MD simulations; these structures were back-
mapped to all atoms and transferred to the model for the nanodisc. 
Last, from these models, we calculated the SAXS data of hGHR-GFP 
embedded in the nanodisc and compared to and refined against the 
SAXS data.
The semianalytical model of the SAXS scattering intensity from 
nanodisc-embedded hGHR-GFP (Fig. 5A) was calculated through 
the absolute squared sum of four scattering amplitude components 
arising from, respectively, the ECD-TMD, the ICD, the GFP, and 
the surrounding nanodisc (see Materials and Methods). The model, 
which implicitly includes the scattering cross-terms between the 
different components and take their internal phases into account, 
was implemented through the WillItFit platform (48). As in our 
previous work (26), we used a hybrid approach to the modeling, 
where different computational approaches were applied and com-
bined for the four different components. Briefly, the ECD-TMD, 
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which is connected through a flexible linker between the ECD and 
TMD, was represented as a single rigid body through the atomic 
coordinates of one of the models produced with Rosetta (see Materials 
and Methods). The disordered ICD and its ensemble of conforma-
tions was modeled with a Gaussian random coil model parame-
trized by its Rg with the center of mass displaced one Rg from the 
disc surface, but where the connections at the two ends, respectively, 
to the TMD and the GFP, were disregarded. The GFP attached to 
the ICD was described through its atomic coordinates (PDB 1EMA) 
and allowed to take a random orientation in a certain “confusion 
volume” in extension of the disordered ICD. For the surrounding 
nanodisc, we allowed, as in our previous work (26, 27, 40), the lipid 
bilayer disc to take a slightly elliptical shape parametrized through 
its axis ratio. This accounts for the combined effect of less than 
maximal lipid loading and shape fluctuations. As in our previous 
work (26, 27, 40), we further constrained and reparametrized the 
underlying geometrical model into physically meaningful molecu-
lar parameters such as the number of POPC per disc and the area of 
POPC per headgroup. The scattering intensity corresponding to the 
model was calculated and fitted on an absolute scale. An excellent 
model fit to the experimental data (2 = 1.5; Fig. 5B, blue) was ob-
tained using a nanodisc containing 122 POPC lipids, each with an 
area per headgroup of 63 Å2 (49), an axis ratio of 1.4 of the elliptical 
bilayer, and an Rg of the Gaussian random coil modeling the ICD of 
73 Å (see details of the model in Materials and Methods and full 
account of model fit parameters in table S3). The number of lipids 
per disc was kept fixed at the value obtained from the experimental 
phosphorous analysis (fig. S4A). Likewise, the axis ratio of 1.4 was 
fixed on the basis of previous analyses (41). We note that the result-
ing fitted POPC area per headgroup agrees well with previous val-
ues obtained for POPC-loaded MSP1D1 nanodiscs (27, 40) and that 
the Rg of the ICD accords with the value we determined for the iso-
lated ICD. The analysis shows that the semianalytical model pro-
vides a low-resolution description of the nanodisc-embedded 
full-length hGHR-GFP and forms a basis for a more detailed mo-
lecular description.
In the next stage, a CG representation was built containing the 
full-length hGHR-GFP receptor embedded in a POPC bilayer 
(Fig. 5C). The simulation included the signal peptide and, hence, 
residues −18 to 620 (total of 638 residues) of the hGHR plus GFP. This 
full-length hGHR-GFP model was simulated with Martini 3 using 
the 10% increase in the strength of protein-water interactions 
found optimal for simulation of the hGHR-ICD. We ran 20 different 
2-s-long simulations and extracted 300 conformations (one every 
5 ns) from each trajectory, discarding the first 500 ns of each run to 
allow for equilibration, providing a total of 6000 conformations of 
hGHR-GFP. These were back-mapped to all-atom representations 
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Fig. 5. Model of the full-length hGHR-GFP in nanodiscs. (A) Schematic representation of the semianalytical Gaussian random coil (SA-GRC) model. (B) Fits of the SA-
GRC to the SAXS data of nanodisc-embedded hGHR-GFP (with GFP) (blue), the ensemble of 6000 conformations taken from the hGHR-GFP +POPCpws10 simulations embedded 
in the nanodisc model (gray), their ensemble average (green), and reweighted ensemble average (red). (C) Representative snapshot from one of the hGHR-GFP + POPCpws10 
simulations (see Materials and Methods). POPC lipids are shown as gray sticks; protein is depicted in surface representation. Some lipids and all water and ions are omitted 
for clarity. (D) Distribution of Rg from 6000 all-atom conformations obtained from the hGHR-GFP + POPCpws10 simulation after reweighting against the SAXS data. The 
values are shown both for the full-length protein (blue) and for the individual structural components: ECD (orange), ICD (green), and ICD-GFP (red).
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had been optimized through the semianalytical approach and fol-
lowing the WillItFit-based procedure previously described (48). 
SAXS scattering curves were calculated from the obtained ensemble 
(Fig. 5B, gray) and averaged, taking the mean I(q) of the 6000 indi-
vidual curves for each value of q (Fig. 5B, green). Comparison to the 
experimental SAXS data showed that the MD-derived model, despite 
not being refined against the experimental data, provided a relatively 
good fit to the experiments (Fig. 5B, green) with a 2 of 19. We used 
the BME approach (31) to improve agreement with the data further. 
We tuned the hyperparameter, , which sets the balance between 
the information from the SAXS data and the force field to  = 500 
(fig. S5, A and B). This resulted in an ensemble effectively containing 
≈70% of the conformations (eff = 0.73) from the simulation and 
obtained a considerable improvement of the fit (2 = 7.0; Fig. 5B, red). 
The resulting model thus combines information about the conform-
ational preferences of hGHR-GFP encoded in both the martini 
model and SAXS data.
We proceeded to analyze the structural properties of hGHR-
GFP described by the reweighted ensemble. Looking at the individual 
domains within the full-length protein, we found (reweighted) Rg 
values of 60 ± 4 Å for hGHR-ICD, 62 ± 4 Å for hGHR-ICD-GFP, 
and 27 ± 2 Å for the hGHR-SP + ECD (Fig. 5D). Measurement of 
the reweighted average helix tilt angle (16° ± 1°) (see fig. S5C) shows 
that the TMD remains nearly parallel to the axis normal of the mem-
brane plane as suggested by the XRD and OCD results obtained on 
the isolated hGHR-TMD. The ICD remained disordered and, for 
the most part, remained avoiding the membrane. Long-lived con-
tacts and penetration of the bilayer were observed only for the intra-
cellular juxtamembrane region (Q272-M277) and the Box1 motif 
(L278-K287) of the ICD, as well as for some residues from the ECD-
TMD linker (fig. S5D, inset), in line with previous reports (9). Visual 
inspection of the trajectory (movie S1) showed that the ECD-TMD 
linker remained flexible, allowing the ECD to adopt a range of 
orientations while remaining mostly upright, as shown by the angle 
between the principal axis of the D2 domain and the z axis (reweighted 
average, 34° ± 3°; fig. S5E). We note that the D1 domain remained 
far from the lipid surface. The N-terminal tail (N-tail) of the ECD 
remained disordered without long-lived contacts with the folded 
part of the ECD or the membrane.
In summary, our integrative model of the full-length monomeric 
hGHR in a nanodisc, containing almost equal amounts of structural 
order and disorder, combines information from molecular simula-
tions and SAXS data recorded on the complex molecular system. In 
this way, the model provides the first experimentally derived detailed 
molecular insight into the structure of an intact, full-length class 1 
cytokine receptor in a lipid membrane carrier system.
DISCUSSION
Membrane proteins take on a variety of different topologies, sizes, 
and functions, and large portions of membrane proteins exist in 
tripartite structures that require different handling schemes and 
methodological studies. Such complexities are further amplified for 
membrane proteins having large fractions of structural disorder 
(21, 50, 51), which impose obstacles to classical structural biology. 
Thus, different topologies and order/disorder dispositions require 
different approaches, and one particular group of membrane pro-
teins falls between the cracks by being too small and unstructured 
for cryo-EM, too large for NMR spectroscopy, and too dynamic for 
x-ray crystallography. An important subgroup of these membrane 
proteins, which plays key biological roles, is the cytokine recep-
tor family.
In the present work, we examined the structure of an archetypal 
and particularly challenging membrane protein, the cytokine receptor 
hGHR, for which 50% of its chain is intrinsically disordered (Fig. 6). 
The structure of the monomeric hGHR revealed that when inserted 
Fig. 6. The ensemble structure of membrane-embedded full-length hGHR-GFP. (A) Representative ensemble of conformations obtained from the last 1.5 s of each 
of the 20 runs of 2-s hGHR-GFP + POPCpws10 simulations. Color scheme and representations as in Fig. 5C. (B) Examples of the multitude of domain orientations of hGHR-
GFP in the membrane. In the first panel, the structures of hGH (PDB 3HHR_A; orange) and of JAK2-FERM-SH2 (PDB 4Z32; red) are shown. Color scheme and representation 
of hGHR and POPC as in Fig. 5C.
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in a bilayer mimetic, neither the ECD nor the long, disordered ICD 
engage in long-lived contacts with the membrane. This is remark-
able, although it should be noted that the lipids used in the current 
study do not fully mimic the complexity of native membranes by, 
e.g., lacking phosphoinositides or/and cholesterol, just as the pro-
teoglycan layer on the extracellular side and the cytoskeleton on the 
inside are missing. We did, however, capture some lipid interactions 
by the intracellular juxtamembrane region (fig. S5D), which have 
been previously described (9). It is possible that the native composi-
tion of the bilayer may influence the conformation of the receptor, 
but, inherently, there is no affinity for the POPC bilayer. Thus, the 
intracellular, disordered domain protrudes from the bilayer and 
into the cytosol. Its average Rg of 65-70 Å corresponds to an average 
end-to-end distance of about twice this value. This defines its 
capture distance and the large search volume (Fig. 6 and fig. S5F), 
which allows it to scout for and engage with kinases, phosphatases, 
and regulatory proteins such as the signal transducer and activator 
of transcription (STAT), suppressors of cytokine signaling, and the 
cytoskeleton (52).
A particular noteworthy observation from the structure of hGHR 
is the disordered, ~30-residue N terminus of the ECD, which has 
been neglected in all previous structural studies. The role of this 
N-terminal IDR in GHR function is unknown, but N-terminal 
IDRs are present in other family members, including the EPOR. An 
isoform of the GHR with a 22-residue deletion in the disordered 
N-tail (d3-GHR) shows altered extracellular signal–regulated kinase 
1/2 signaling but unaltered STAT5 signaling, and d3-GHR individuals 
show increased life spans (53). Thus, key functional relevance is cou-
pled to the N-tail. A search in the eukaryotic linear motifs database 
(54) suggests the presence of a glycosaminoglycan (GAG) attachment 
site, 1FGFS4, in the N-tail. Of relevance to this, the WSXWS motif, 
which in hGHR is YGEFS, constitutes a C-mannosylation site linking 
the C1 atom of the -mannose to the indole C2 atom of the trypto-
phan (3, 12). The WSXWS motifs has also been suggested to bind 
GAGs (12), so it is possible that the disordered N-tail of hGHR play 
similar roles as the WSXWS motif, and we notice a degenerate motif 
of this kind, also in the N-tail, given by the sequence 16WSLQS20. 
Nonetheless, the function of the disordered N-tail of hGHR remains 
unestablished.
The integrative nature of our approach to determine the struc-
ture of the hGHR required development and optimization of several 
protocols. This was particularly necessary during the modeling and 
fitting of the SAXS data based on the combined semianalytical and 
experimentally driven molecular modeling approach to account for 
the structure and large flexibility of the hGHR. Key to the success 
was a scaling of the strength of the protein-water interaction in the 
CG-MD simulations of the ICD and full-length hGHR. This enabled 
reliable fits to the disordered chain in terms of Rg. On the semi-
analytical modeling side, we have expanded our previous approaches 
to interpret scattering data from bare nanodiscs and rigid membrane 
proteins incorporated into these discs (26, 27, 40), to now also 
allow for modeling membrane proteins with significant amounts of 
structural disorder. We emphasize that even if the parameters of the 
GHR model are custom-fitted to the hGHR-GFP system, the approach 
is fully generalizable and may be adapted to membrane proteins 
of similar topology provided that high-quality scattering data are avail-
able. Thus, the use of this integrative semianalytical and MD simulation–
based approach suggests that SAXS (and SANS) in combination with 
MD simulations is a useful way of providing structural insight into 
otherwise “method orphan” membrane proteins, particularly high-
lighting the interdomain orientations. This opens for more systematic 
investigations of, for example, single-pass transmembrane proteins 
in different environments, e.g., with respect to the lipid composition, 
the buffer environment, or with binding partners to understand how 
these very dynamic membrane proteins transduce information across 
the membrane. Furthermore, structures of not only other single- pass 
membrane proteins with similar complexity such as the cadherins 
and cell adhesion molecules (e.g., Down syndrome cell adhesion 
molecule) but also membrane proteins with long, disordered regions 
such as the solute carrier family 9, type II receptor serine/threonine 
family, and palmitoyl transferases now become accessible.
A key observation made possible from acquiring data on the full-
length hGHR is the lack of restriction on the relative orientation of the 
domains (Fig. 6). Not only is the ICD and the N-tail disordered but 
also the flexible linker joining the ECD and TMD, which combined 
with the lack of membrane association allow them to freely reorient 
relative to each other, at least in the free state (Fig. 6). Thus, in addi-
tion to structure, it becomes important to consider how the flexibil-
ity of the entire chain takes on roles in signaling. From our studies, 
we were not able to derive whether correlated motions between the 
ECD and the ICD exist. However, once the hGH binds to the ECD, 
changes in conformation and flexibility may propagate along the chain, 
reaching the ICD and bound protein partners, eliciting signaling. 
Similar suggestions were put forward on the basis of data from solid- 
state NMR studies on the epidermal growth factor receptor, reveal-
ing increased dynamics in the bound state (55). Since the JAK2 
binding site only constitutes ~6% of the ICD, and the STAT5 dock-
ing sites are ~200 to 300 residues away from it (56), conformational 
changes involving redistribution of the structural ensemble of the 
long, disordered region need to be achieved in a controlled manner. 
In addition, the ICD contains many short linear motifs (SLiMs), dis-
tributed along the chain in SLiM hotspots (8), and the space occu-
pied by the free ICD (fig. S5, E and F) may therefore enable room 
for generation of larger, supramolecular signaling complexes. With 
the presence of two disordered chains in a dimer, the occupied space 
of each ICD chain may be reduced because of steric exclusion, 
affecting the formation and content of supramolecular complexes. 
With a structure of a full-length membrane protein embedded in a 
realistic membrane scaffold and containing a large disordered chain 
at hand, the understanding of regulation of signaling by disordered 
chains, often present in higher-order assemblies of several chains, 
now has a molecular platform from which new questions can be 
tackled.
MATERIALS AND METHODS
hGHR-ECD expression and purification
The DNA sequence coding for hGHR-ECD (1 to 245, C242S, no 
signal peptide) in a pET11a was bought from GenScript and trans-
formed into competent Rosetta2 (DE3)pLysS cells. These were grown 
in 1 liter of LB medium with 3% (v/v) ethanol containing ampicillin 
and chloramphenicol (100 g/ml) to OD600 (optical density at 600 nm) = 
0.6 to 0.8, and induced by addition of 0.5 mM isopropyl--d- 
thiogalactopyranoside (IPTG) for 4 hours at 37°C and 160 revolu-
tions per minute (RPM). The cells were harvested by centrifugation 
(5000g for 15 min) and resuspended in one-time phosphate-buffered 
saline (PBS) (140 mM NaCl, 2.7 mM KCl, 10 mM Na2H2PO4, and 
1.8 mM KH2PO4) (pH 7.4) containing 25% (w/v) sucrose and 5 mM 
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EDTA. The cells were lysed on ice by sonication using an UP400S 
ultrasonic processor, 6 × 30-s sonication followed by 30-s rest at 
50% amplitude. Following centrifugation (20,000g, 4°C) for 25 min, 
the pellet was resuspended in one-time PBS (pH 7.4) containing 
25% (w/v) sucrose and 5 mM EDTA, repeated three times in total. 
The pellet was solubilized in 500 ml of 50 mM tris-HCl (pH 8.5), 
10 mM -mercaptoethanol (bME), and 6 M urea, heated for 5 min at 
55°C, and left O/N (overnight) with slow stirring at 4°C. The amount 
of hGHR-ECD was estimated on an SDS-PAGE by comparing to 
the LMW (low molecular weight and diluted to a concentration less 
than 0.1 mg/ml in 50 mM tris-HCl (pH 8.5), 10 mM bME, and 6 M 
urea. To refold, hGHR-ECD was dialyzed against 4 liters of 150 mM 
NaCl, 50 mM tris-HCl (pH 8.5), 10/1 mM cysteamine/cystamin at 
4°C, and a molecular weight cutoff of 12 kDa until the urea con-
centration was below 0.1  M. Following centrifugation at 20,000g 
for 15 min, the sample was placed on ice and stirred slowly, while 
ammonium sulfate was added to a final concentration of 75% (w/v) 
and then left for 2 hours. The solution was centrifuged at 12,000g at 
4°C for 25 min, and the pellet was dissolved in 100 ml of Milli-Q 
water and left for 2 hours, followed by dialysis against 30 mM 
NH4HCO3 (pH 8.0) overnight at 4°C. After centrifugation at 13,000g 
for 15 min, the supernatant was concentrated using a Millipore spin 
filter (10 kDa cutoff) and applied to a Superdex 75 16/85 column (GE 
Healthcare) at 4°C, 150 mM NaCl, and 30 mM NH4HCO3 (pH 8.5). 
Selected fractions were reapplied to a Superdex 200 increase 10/300 
GL column in 20 mM Na2H2PO4 (pH 7.5) and 150 mM NaCl before 
SAXS measurements.
hGHR-ICD expression and purification
The coding region for hGHR-ICD (S270-P620) was cloned into a 
pGEX-4T-1 vector, containing an N-terminal glutathione S-transferase 
(GST)–tag followed by thrombin cleavage site and transformed into 
Bl21(DE3) cells. Expression was done in 1 liter of terrific broth (TB) 
medium containing ampicillin (100 g/ml). At OD600 = 0.6 to 0.8, 
cells were induced by 1 mM IPTG for 4 hours at 37°C and 160 RPM. 
Cells were harvested by centrifugation and resuspended in 40 ml of 
one-time PBS (pH 7.4), 0.1% (v/v) Triton X-100, and a tablet com-
plete EDTA-free protease inhibitor cocktail. The cells were lysed on 
ice by sonication using an UP400S ultrasonic processor, four times 
30-s sonication followed by 30-s rest at 100% amplitude. Following 
centrifugation (20,000g, 4°C) to remove cellular debris, the lysate 
was applied to a glutathione Sepharose 4 fast flow column (GE 
Healthcare) and incubated for 2 hours at 25°C. The column was washed 
with 50 ml of one-time PBS (pH 7.4) and eluted 20 ml of 50 mM 
tris-HCl and 10 mM reduced glutathione (pH 7.4). The eluted solu-
tion was dialyzed against 1  liter of 20 mM tris-HCl and 150 mM 
NaCl (pH 7.4) at 4°C. The GST-tag was cleaved off by the addition 
of 20 U of thrombin per liter of culture, leaving residues GS in the 
N terminus. The sample was then concentrated; 10 mM dithiothreitol 
was added and heated to 72°C for 5 min, incubated on ice, and cen-
trifuged for 20,000g at 4°C for 10 min. A final purification on a 
Superdex 200 increase 10/300 GL column (GE Healthcare) in 20 mM 
Na2H2PO4 (pH 7.5) and 150 mM NaCl was done, and selected frac-
tions were used for SAXS measurements.
hGHR-ICD-GFP-H10 expression and purification
The coding region for hGHR-ICD (S270-P620) including an N-terminal 
methionine, C-terminal Tobacco Etch Virus (TEV) cleavage 
(ENLYFQS) site followed by a yeast enhanced GFP (EGFP) (57), 
and 10 histidines (hGHR-ICD-GFP-H10) in a pET-11a vector was 
bought from GenScript. Expression was done in 1 liter of TB medium 
(for SAXS) and in 15N-labeled minimal medium [22 mM KH2PO4, 
62.5 mM NaH2PO4, 85.6 mM NaCl, 1 mM MgSO4, 1 ml of “trace 
element solution,” 4 g of glucose, and 1.5 g of NH4Cl (15N-labeled 
nitrogen)] (for NMR) containing ampicillin (100 g/ml). At OD600 = 
0.6 to 0.8, expression was induced by 1 mM IPTG for 3 hours at 
37°C and 160 RPM. Cells were harvested by centrifugation and re-
suspended in 40 ml of one-time PBS (pH 7.4) and a tablet of cOm-
plete EDTA-free protease inhibitor cocktail. The cells were lysed on 
ice by sonication using an UP400S ultrasonic processor, four times 
30-s sonication followed by 30-s rest at 100% amplitude. Following 
centrifugation (20,000g, 4°C), the pellet containing hGHR-ICD-GFP-H10 
was solubilized by adding 40 ml of 20 mM NaHCO3 (pH 8.0), 150 
mM NaCl, and 8 M urea. Following centrifugation (20,000g, 4°C), 
the supernatant was refolded by dialysis in two steps: first, by dialy-
sis in 4 liters of 20 mM NaHCO3 (pH 8.0), 150 mM NaCl, and 4 M 
urea at 4°C using 3 kDa of molecular weight dialysis bag cutoff for 
4 hours and then in 4 liters of 20 mM NaHCO3 (pH 8.0) and 150 mM 
NaCl at 4°C overnight. Following centrifugation (20,000g, 4°C), the 
supernatant was applied to a prepacked 5 ml of Ni resin column. 
The column was washed with three column volumes (CVs) of 20 mM 
NaCHO3 (pH 8), 150 mM NaCl, and 10 mM imidazole and eluted 
using 20 mM NaCHO3 (pH 8.0), 150 mM NaCl, and 250 mM imidazole. 
Fractions containing hGHR-ICD-GFP-H10 were concentrated and ap-
plied to a Superdex 200 16/60 increase column in 20 mM NaH2PO4/
Na2H2PO4 (pH 7.5) and 150 mM NaCl. Fractions containing 
hGHR-ICD-GFP-H10 were analyzed by SDS-PAGE, and selected 
fractions were used for SAXS and NMR experiments.
hGH purification
hGH in a pJExpress414 was bought from ATUM, USA (formerly 
DNA2.0) and transformed into competent BL21 (DE3) cells. These 
were grown in 1  liter of TB containing ampicillin (100 g/ml) to 
OD600 = 0.6 to 0.8 and induced by addition of 1 mM IPTG for 
4 hours at 37°C and 160 RPM. Cells were harvested by centrifuga-
tion (5000g, at 4°C, 25 min) and resuspended in 50 ml of 50 mM 
tris, 0.5 mM EDTA (pH 8.0), and 1 mM phenylmethylsulfonyl flu-
oride (PMSF). Cells were lysed on ice by sonication using an UP400S 
ultrasonic processor, five times 30-s sonication followed by 30-s rest 
at 50% amplitude. Following centrifugation at 10,000g at 4°C for 
15 min, the pellet was resuspended in 20 ml of 10 mM tris, 1 mM 
EDTA (pH 8.0), and 1 mM PMSF. The pellet was recentrifuged two 
times, and the supernatant was discarded and solubilized in 250 ml 
of 5 M guanidinium chloride (GuHCl), 200 mM Na2HPO4/NaH2PO4 
(pH 7.0), and 15 mM bME. The solution was heated for 10 min at 
55°C and stirred mildly for 2 hours at room temperature. The solu-
tion was diluted in denaturation buffer [5 M GuHCl, 200 mM 
Na2HPO4/NaH2PO4 (pH 7.0), and 15 mM bME] to reach an hGH 
protein concentration below 0.1 mg/ml. The solution was dialyzed 
in a 5-liter beaker, with a drain on the top, and filled with 5 M GuH-
Cl, 200 mM Na2HPO4/NaH2PO4 (pH 7.0), and 15 mM bME. A per-
istaltic pump was used to add refolding buffer [20 mM NH4HCO3 
(pH 8.0) and 200 mM NaCl] at the bottom of the beaker with a 
flow rate of 1.5 ml/min. After 3 days, when the GuHCl concentra-
tion was below 1.5 M, the dialysis bags were transferred to a new 
5-liter beaker with 20 mM NH4HCO3 (pH 8.0) and 200 mM NaCl 
and dialyzed three times until the concentration of GuHCl was 
below 0.1 M. Following centrifugation for 18,000g for 10 min, the 
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supernatant was concentrated using a Millipore Pellicon mod-
ule to approximately 30 ml. The solution was applied to a Super-
dex 75 26/600 column in 20 mM NH4HCO3 and 100 mM NaCl (pH 
8.0). Selected fractions were dialyzed against 5 liters of 20 mM tris (pH 
8.0) twice and applied to a HiTrap QFF of 5 ml. The sample was 
eluted in 20 mM tris (pH 8.0) by a salt gradient from 0 to 1 M NaCl 
at a flow rate of 5 ml/min over 20 CV. Selected fractions were 
flash- frozen in liquid nitrogen and left at −20°C before use.
Analytical SEC
Analytical SEC experiments of a set of samples with various ratios 
of hGH:hGHR-ECD were run on Superdex 200 increase 10/300 GL 
column in 20 mM Na2HPO4/NaH2PO4 (pH 7.4) and 100 mM NaCl 
at room temperature with a flow rate of 0.5 ml/min. Protein sample 
concentration was in the micromolar range but varied. The column 
was calibrated using conalbumin (75 kDa), ovalbumin (44 kDa), 
carbonic anhydrase (29 kDa), ribonuclease A (13.7 kDa), acetone, 
and blue dextran, and apparent partition coefficient, Kav, was deter-
mined for all peaks.
Circular dichroism spectroscopy
Far-ultraviolet CD spectra were recorded on 10 M hGHR-TMD in 
2 mM DHPC, 5 M hGH, and 5 M hGHR-ECD in 10 mM Na2HPO4/
NaH2PO4 (pH 7.4). The spectra were recorded on a Jasco J-810 
spectropolarimeter in a 1-mm quartz glass Suprasil cuvette (Hellma) at 
20°C. A total of 10 scans were accumulated from 260 to 190 nm for 
each sample, and buffer background was recorded at identical setting 
and subtracted. For hGHR-TMD, the background included 2 mM 
DHPC. The scan mode was continuous with a speed of 10 nm/min 
and a data pitch of 0.1 nm. The spectra were processed and smoothened 
(means-movement method, convolution width of 25) and converted 
into mean residue ellipticity values.
hGHR-TMD purification
hGHR-TMD was expressed in E. coli and purified as previously 
described (32).
Oriented circular dichroism
hGHR-TMD was dried under a flow of N2 and subsequently dissolved 
in MeOH:CHCl3 (5:1) to reach a final stock solution of hGHR-
TMD (0.4 mg/ml). To validate the concentration, 100 l of the stock 
solution was dried under N2 flow and resuspended in 100 l of 50 mM 
SDS in phosphate buffer (pH 7.0), and the absorbance at 280 nm 
was measured. Lipid stock solutions of POPC, DOPC, and POPC/
POPS (3:1) were prepared in MeOH:CHCl3 (1:1) at 0.25 and 5 mg/ml. 
The protein and lipid stock solutions were mixed in the following 
L:P ratios: 40:1, 50:1, 70:1, 100:1, 150:1, and 200:1. Six micrograms 
of protein was applied to a quartz glass with a Hamilton pipette for 
each experiment. The sample was spread over a fixed circular area 
on the glass and subsequently dried under vacuum for 3 hours to 
remove the MeOH:CHCl3. The dried sample was mounted in a 
sample holder and was hydrated overnight in a chamber with a sat-
urated K2SO4 solution at 20°C. Last, the samples were loaded into a 
rotor in a Jasco J-810 spectropolarimeter, and the spectra were 
recorded from eight different angles: 0°, 45°, 90°, 135°, 180°, 225°, 
270°, and 315°. Each spectrum was measured twice from 260 to 
180 nm with a scanning speed of 20 nm/min, a data pitch of 0.1, and 
a response time of 8 s. The spectra were averaged, and the reference 
OCD spectra from samples with the same amount of lipid were 
subtracted. The OCD spectra were recorded from eight different 
angles to even out linear dichroism (fig. S2C) (37). The spectra from 
different angles were averaged, background subtracted, and nor-
malized to the intensity at 222 nm. High-voltage effects prevented 
the measurement of higher L:P ratios.
X-ray diffraction
Highly oriented multilamellar membranes were prepared on single- 
side polished silicon wafers. POPC (Avanti), POPS (Avanti), and 
1,2-dimyristoyl-sn-glycero-3-phospho-l-serine (Sigma-Aldrich) were 
mixed with hGHR-TMD at 2 and 20 mol % concentrations in 
2,2,2-trifluoroethanol:chloroform [1:1 (v/v)] at a solution concentration 
of 18 mg/ml. The wafers were sonicated in 1,2-dichloromethane for 
30 min and then rinsed with alternating methanol and water 
(18.2 megaOhm·cm). The wafers were dried, and 75 l of the solu-
tion was deposited. After drying, the samples were placed in a vacu-
um for 24 hours at 37°C to allow for trace solvent evaporation and 
annealing. Samples were then hydrated in a closed chamber at 97% 
relative humidity with a separate K2SO4-saturated solution for 
48 hours before scanning.
XRD data were obtained using the Biological Large Angle Dif-
fraction Experiment (BLADE) at McMaster University. BLADE 
uses a 9-kW (45 kV, 200 mA) CuK rotating anode at a wavelength 
of 1.5418 Å using a Rigaku HyPix-3000 two-dimensional semicon-
ductor detector with an area of 3000 mm2 and 100 m2 of pixel size 
(58). All samples were prepared and measured in replicates to check 
for consistency. EDPs were determined from specular reflectivity, as 
previously described (36). The lamellar spacing, dz, was determined 
from the spacing of the reflectivity Bragg peaks. Hermans orienta-
tion function was determined by integrating the intensity of the third 
Bragg peak as function of the meridonal angle  (the angle relative 
to the qz axis), as described in (59). The CYANA and CS-Rosetta 
models of the monomer and the Protein Data Bank (PDB) structure 
of the dimer (PDB 5OEK) were used and fitted to the difference 
electron density. The calculation uses the electronic distribution of 
each atom of the molecule. To account for thermal motions, a 
Gaussian distribution, with a half width of 3.5 Å, is placed at the 
correct position, and all the atomic contributions are added. The 
linear electron density is then calculated by projecting the calculated 
electronic distribution on a linear axis and fitting to the experimental 
data. Position and tilt angle were determined from the fit by shifting 
the molecule along the z axis and varying the z projection (60).
NMR spectroscopy and structure of the TMD
NMR spectra were recorded on a 750-MHz (1H) Bruker AVANCE 
spectrometer equipped with a cryogenic probe. Unless otherwise 
specified, all NMR samples contained 10% (v/v) D2O and 1 mM 
4,4-dimethyl-4-silapentane-1-sulfonic acid (DSS). Proton chemical 
shifts were referenced internally to DSS at 0.00 parts per million (ppm), 
with heteronuclei referenced by relative gyromagnetic ratios. Free 
induction decays were transformed and visualized in NMRPipe or 
TopSpin (Bruker Biospin) and analyzed using CcpNmr Analysis 
software. For hGHR-TMD, all NMR spectra were recorded at 37°C 
in 2 mM tris(2-carboxyethyl)phosphine (TCEP), 0.05% (v/v) NaN3, 
50 mM NaCl, and 20 mM Na2HPO4/NaH2PO4 (pH 7.4). The spec-
tra for backbone assignments of hGHR-TMD [HNCO, HNCAHC, 
HNCA, HNCACB, CBCA(CO)NH, 1H, and 15N-HSQC] were 
measured on 1 mM 13C,15N-hGHR-TMD solubilized in 210 mM 
DHPC. Secondary structure content was evaluated from backbone 
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chemical shifts using the MICS program (33). R2 transverse relax-
ation rates of 0.5 mM 15N-hGHR-TMD in 110 mM DHPC were 
determined from a series of 1H,15N-HSQC spectra with varying re-
laxation delays between 10 and 250 ms and triple replica at 130 ms. 
The relaxation decays were fitted to single exponentials and relaxation 
times determined using CcpNmr Analysis software. A low-resolution 
model of hGHR-TMD was calculated using CYANA (34) including 
only dihedral angle restraints derived from the backbone chemical 
shifts using TALOS (61). Standard settings were used calculating 
50 conformers with 4000 torsion angle dynamics steps. The 10 best 
conformers, with the lowest CYANA target function score, was 
used for further modeling. In addition, a model of hGHR-TMD was 
calculated using CS-Rosetta (35). The chemical shifts obtained for 
the hGHR-TMD were used as an input for the CS-Rosetta server 
(https://spin.niddk.nih.gov/bax/nmrserver/csrosetta/) from which 
3- and 9-nucleotide oligomer fragments were obtained and used for de 
novo modeling. We adapted previously described protocols (62) to 
the relevant parts of the calculation: (i) ab initio modeling using the 
NMR-derived chemical shifts, (ii) definition of the membrane- spanning 
region, and (iii) rescoring of the Rosetta energy considering the chemical 
shifts. A total of 1000 models were generated. Clustering of the 10 
lowest-energy models around the lowest one, with C-RMSD < 2 Å for 
the W249 – K271 region, indicated successful prediction (see Fig. 2D).
All NMR data of hGHR-ICD and hGHR-ICD-GFP-H10 were ac-
quired at 5°C to minimize amide exchange in 1 mM TCEP, 150 mM 
NaCl, and 20 mM Na2HPO4/NaH2PO4 (pH 7.4). 1H,15N-HSQC 
spectra were acquired at concentrations of 150 M for 15N-hGHR-
ICD and 100 M for 15N-hGHR-ICD-GFP-H10. The hydrodynamic 
radii (Rh) of hGHR-ICD and hGHR-ICD-GFP-H10 were determined 
from a series of 1H,15N-HSQC spectra with preceding pulse-field 
gradient stimulated-echo longitudinal encode-decode diffusion fil-
ter and with the gradient strength increasing linearly from 0.963 to 
47.2 G cm−1. To determine the diffusion coefficients (D), the decay 
curves of the amide peaks were plotted against the gradient strength 
and fitted in Dynamics Center (Bruker) using
  I =  I 0 exp(– 10 4  D x 
2   2   2 ( −  / 3 )) 
in which I is the intensity of the NMR signal at the respective gradient 
strength, I0 the intensity without applied gradient, x the gradient strength 
in G cm−1,  = 26,752 rad G s−1,  = 3 ms, and  = 250 ms. RH was 
calculated from the diffusion coefficient using the Stokes- Einstein 
relation, RH = kBT/(6D), with  being the viscosity of water at 5°C.
Production of full-length hGHR
See Kassem et al. (21) for expression, purification, and reconstitution 
of hGHR-GFP in POPC-containing MSP1D1 nanodiscs. pMSP1D1 
was a gift from S. Sligar (Addgene plasmid no. 20061; http://n2t.
net/addgene:20061; RRID:Addgene_20061) (63).
Native mass spectrometry
Purified hGHR-GFP in detergent was desalted and concentrated us-
ing C4 ZipTips (Merck Millipore), eluted into 50% acetonitrile/0.1% 
formic acid, and directly infused into an Orbitrap Fusion Tribrid mass 
spectro meter equipped with an offline nanospray source using bo-
rosilicate capillaries (Thermo Scientific). The capillary voltage was 1.5 kV 
in positive ionization mode, and the pressure in the ion-routing multipole 
was maintained at 0.11 torr. Ten percent of HCD activation energy 
in the ion trap was used to dissociate any residual detergents from the 
protein. Spectra were acquired in the Orbitrap mass analyzer operated 
in high mass mode between 1500 to 6000 mass/charge ratio (m/z) 
with an injection time of 10 ms and a resolution of 60,000 full width 
at half maximum at 200 m/z. Data were analyzed using Excalibur (Thermo 
Scientific) and UniDec (unidec.chem.ox.ac.uk) software packages.
Phosphorus analysis
The POPC-hGHR-GFP ratio of the formed nanodiscs with POPC-
hGHR-GFP inserted was determined by phosphorus analysis (43). 
This was done by hydrolyzing POPC in H2SO4 to release free phosphate 
(PO4−3), which reacted with molybdate to produce a blue chromo-
phore, absorbing at 812 nm. A series of phosphate standards from 0 to 
80 nM Na2HPO4 and hGHR-GFP in MSP1D1 at approximately 1 M 
were prepared. Aliquots of 175 l of each sample were transferred to 
glass tubes. HClO4 was added [400 l, 72% (v/v)] to each sample, and 
the glass tubes were loosely closed using glass pearls. The samples 
were heated to 180°C in a heating block in a fume hood for 1 hour 
and then left at room temperature to cool for 30 min. Four milliliters 
of 125 mM (NH4)6Mo7O24 × four H2O was added to each sample 
and vortexed, followed by addition of 500 l of 10% (w/w) ascorbic 
acid and vortexed again. Samples were then heated to 80°C for 10 min 
in a water bath and subsequently cooled in ice water. Absorption was 
measured at 812 nm. A phosphate standard curve was generated, using 
the Na2HPO4 standards, by linear regression and was used to determine 
the content of phosphate in the hGHR-GFP in MSP1D1 samples.
Gel quantification of hGHR-GFP-loaded nanodiscs
Standards of hGHR-GFP and MSP1D1 with a known absorption at 
280 nM were prepared and loaded in different amounts of the same 
gel and three aliquots of hGHR-GFP-loaded nanodiscs taken from 
three different positions of the SEC elution profile (fractions 1, 2, 
and 3). The gels were stained with Coomassie brilliant blue G-250 
(Bio-Rad) and subsequently destained in 15% (v/v) ethanol, 5% (v/v) 
acetic acid, and 5% glycerol (v/v). Gel images were obtained on a LAS 
4000 imager (GE Healthcare, USA), and the images were quantified in 
ImageJ. The intensities of the standards were fitted by linear regression, 
and the amount of hGHR-GFP relative to MSP1D1 was quantified 
accordingly.
Microscale thermophoresis
hGH was labeled with NT-647-NHS (64) using the Monolith NT 
Protein Labeling Kit RED-NHS (NanoTemper Technologies) for 
1 hour at room temperature with NT-647-NHS at a molar ratio of 
1:3 in labeling buffer following the protocol. These conditions favor 
the modification of the N-terminal amino group. Free dye was sep-
arated from reacted dye using the provided desalting column. The 
ratio between fluorophore and protein was 0.2. The equilibrium 
binding between 20 nM NT-647-NHS–labeled hGH and hGHR 
(MSP1D1) was calculated from the change in thermophoresis Fnorm = 
Fhot/Fcold measured on a Monolith NT.115 (NanoTemper Tech-
nologies). For hGHG120R, the raw fluorescence change was used to 
determine the binding affinity. A twofold dilution series of 
monomeric hGHR-GFP from 750 nM to 23 pM was prepared in 20 mM 
Na2HPO4/NaH2PO4 (pH 7.4) and 100 mM NaCl and measured in 
triplicates. Samples were loaded into the Monolith NT.115 Premium 
Capillaries (NanoTemper Technologies), and the thermophoresis and 
raw fluorescence signals were measured at 25°C with a light-emitting 
diode power of 80% and an infrared laser power of 100%. The dis-
sociated constant Kd was obtained by fitting the data by
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 Y =  Y 0 +  
 Y f −  Y 0   ─2  [P] total 
 × ( K d +  [P] total + X −  
√ 
__________________________
   ( K d  +  [P] total  + X) 
2 − 4  [P] total X )  
where Y is the measured fluorescence/MST, X is the ligand concen-
tration, [P]total is the total concentration of the protein, Yf is the 
estimated end point of the titration, and Y0 is the start point.
N-glycosylation removal by endoglycosidase H
One microgram of purified full-length hGHR-GFP was incubated with 
500 U of Endo-H (New England Biolabs, USA) at 4°C in 20 mM 
NaH2PO4/Na2HPO4 (pH 7.4), 150 mM NaCl, and 5% (v/v) glycerol. 
The sample was separated and analyzed on a 15% SDS-PAGE gel 
and visualized by in-gel fluorescence on a LAS 4000 imager (GE 
Healthcare, USA).
Western blotting
hGHR-GFP was separated on a 15% SDS-PAGE gel and blotted to a 
polyvinylidene difluoride. Horseradish peroxidase–conjugated con-
canavalin A (Sigma-Aldrich, L6397) was used to identify O-glyco-
sylations after Western blotting. Chemiluminescence was detected by 
using the Immobilon Western Chemiluminescent HRP Substrate 
from Millipore and the LAS 4000 imager (GE Healthcare, USA).
Small-angle x-ray and neutron scattering
SAXS data on hGH, hGHR-ECD, and the hGH:hGHR-hECD 1:1 
and 1:2 complexes were collected at the PETRA III, P12 beamline 
(DESY Synchrotron, Hamburg), following standard procedures at 
8°C. All samples were concentrated and run on a Superdex 200 in-
crease 10/300 GL in 20 mM Na2HPO4/NaH2PO4 (pH 7.4) and 150 mM 
NaCl before measuring. The most concentrated top fractions were 
taken, except for 1:1 complex, where the fraction was taken to the 
right of the peak, to make sure the hGH:hGHR-ECD 1:2 complex 
was absent in the sample. hGH was measured at 1.8 mg/ml, ECD at 
3.5 mg/ml, hGH:hGHR-ECD 1:1 complex at 0.3 mg/ml, and the 
hGH:hGHR-ECD 1:2 complex at 1.3 mg/ml. The scattering curves, 
each of which has an average of 40 frames, were recorded, and the 
buffer was measured before and after each sample. The processing 
and preliminary data analysis was done using the ATSAS package 
(65). As a part of the process, buffer scattering curves before and 
after the sample were averaged and subtracted from the scattering 
curve of the sample. The scattering curves were scaled into units of 
1/cm using a measurement of water as secondary standard and sub-
sequently logarithmically rebinned. For the full-length hGHR in MSP1D1, 
in-line SEC-SAXS of the sample in 20 mM Na2HPO4/NaH2PO4 
(pH 7.4) and 150 mM NaCl was performed at BM29 (European Syn-
chrotron Radiation Facility, Grenoble) equipped with a Superose 6 
increase 10/300 GL (GE Healthcare) running at a flow rate of 0.75 
ml/min. In-line SEC-SANS data on the full-length hGHR in MSP1D1 
were recorded on the D22 small-angle scattering diffractometer at 
Institute Laue-Langevin, Grenoble, France. The in-line SEC was 
performed using a the recently commissioned and described 
modular HPLC system (Serlabo) in 20 mM Na2HPO4/NaH2PO4 
(pH 7.4) and 150 mM NaCl on a Superose 6 increase 10/300 GL (GE 
Healthcare) (42, 66). The flow rate was lowered from the 0.75 ml/min 
used in the SEC-SAXS measurements to 0.05 ml/min when the peak 
was reached in the lower-intensity SANS to get as good counting 
statistics on the individual frames as possible. Two settings were used, 
11.2 and 2.0 m (with collimation lengths of 11.2 and 2.8 m, respec-
tively), giving a q range between 0.0044 and 0.46 Å−1. The intensi-
ties were binned into 30-s frames.
Modeling of the hGHR-ECD
To build a model of the full-length hGHR-ECD that covers the same 
sequence of the construct used in the experimental procedures, the 
following steps were performed: (i) We selected a previously deter-
mined crystal structure of the GHR-ECD (chain C of PDB entry 
3HHR, residues 32 to 236) (17). (ii) We built models for the missing 
loops (residues 57 to 61 and 74 to 77) using the MODELLER inter-
face of Chimera (67). (iii) The missing N-terminal (residues 1 to 31) 
and C-terminal (residues 237 to 245) tails were modeled as ensembles 
to capture their flexibility in the fitting of SAXS data. The Rosetta 
(30) routine Floppy tail (29) was used to generate 5000 conforma-
tions of both tails.
Modeling of the hGHR ECD-TMD linker
The linker between the hGHR-ECD and hGHR-TMD (S237-W249) 
is not present in the available structures of hGHR-ECD, and its 
structure may play a relevant role in determining the proper ECD-
TMD orientation. Thus, this linker was modeled to provide a start-
ing conformation of the hECD-TMD region of hGHR for further 
use in the modeling of the full-length hGHR structure. To do this, 
the recently developed mp_domain_assembly protocol (68) in 
Rosetta_MP was used. We used the model described above of the 
ECD with missing loops completed (residues 32 to 236, i.e., without 
the SP and N- and C-terminal tails) and the TMD structure corre-
sponding to an NMR-derived CYANA model (residues 250 to 272). 
A total of 5000 models were built with the best 10 (according to their 
Rosetta score) selected for further analysis, and the best-ranked model 
was used as a rigid body in the semianalytical models of hGHR-GFP 
in a nanodisc and as starting conformation in the building of the 
full-length hGHR-GFP CG model (see below).
Modeling of the hGHR-ICD
We built a model of the hGHR-ICD (residues 288 to 638) as a ran-
dom coil from its sequence using PyMOL. This all-atom model was 
used to build a CG system using the martinize.py and insane.py 
scripts to obtain a system of protein, water, and 150 mM NaCl  with 
the martini 3 (m3.b3.2) (69) topology. The system contained a total 
of 455,457 beads and size of 383 Å by 383 Å by 383 Å. This system 
was used as the initial structure to perform all the GHR-ICD CG 
simulations (see below).
Structural model for the full length hGHR-GFP
A full-length model of intact hGHR-GFP with the signal peptide 
on its N terminus and a GFP on its C terminus was built using the 
different parts modeled separately. A representative conformation 
from the reweighted subensemble of the full-length ECD (residues 
1 to 237) was aligned to the best model of the ECD-TMD to obtain a 
complete ECD-TMD structure (residues 1 to 272). A representative 
structure of the ICD (residues 273 to 620) was taken from the back-
mapped conformation from the CG-MetaD-Rg simulation with 10% 
increase in the protein-water interaction strength (see below). Rota-
tions of the peptide bond between residues 273 and 274 had to be 
adjusted to allow the correct orientation of the ICD with respect to the 
TMD and the membrane plane. EGFP (PDB 1EMA) was added at 
residue 620. The signal peptide (residues −18 to −1) was added to the 
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N terminus of this model as a coil using MODELLER. This all-atom 
model was used to build a CG system using the martini Maker mod-
ule (70) of CHARMM-GUI to obtain a system of protein (hGHR-
GFP) + POPC + water + 150 mM NaCl for the martini 2 force field. 
The topology was later adapted to open the beta version of martini 
3 (m3.b3.2) (69). The final system contains 453,662 beads and has a 
size of 361 Å by 361 Å by 406 Å.
CG-MD simulations
MD simulations were performed with Gromacs 2016, 2018, or 2019 
(71) using the open beta version of the martini 3 (3.b3.2) force field 
(69). In some simulations, we increased the strength of interactions 
between protein and water to avoid excessive compaction of the dis-
ordered regions. To find the optimal factor to change these 
protein-water interactions, we performed two sets of simulations 
of the GHR-ICD system with different values of the protein-water in-
teraction strengths (increased between 5 and 15%). Unbiased simula-
tions were performed with a 5% (5.6 s), 6% (3.1 s), 8% (3.3 s), 
and 10% (5.2 s) increase, while metadynamics simulations (see 
below) were performed with a 10% (10.1 s), 11% (10.1 s), 12% (10.1 
s), 13% (10.1 s), 14% (9.9 s), and 15% (9.4 s) increase. On the 
basis of the best reproduction of Rg and best fit to the hGHR-ICD 
SAXS data (see fig. S3), we chose a 10% increase in interaction 
strength and used this also for the simulation of the hGHR-GFP + 
POPC system.
We performed 20 independent unbiased MD simulations (2 s 
each) of the hGHR-GFP + POPC system with a time step of 5 fs. 
Other simulation parameters, common to all the CG simulations 
performed, were chosen following the recommendations in (72). Briefly, 
the Verlet cutoff scheme was used considering a buffer tolerance of 
0.005 kJ/(mol ps atom). The reaction field method was used for 
Coulomb interactions with a cutoff of 11 Å and a dielectric constant 
of r = 15 for water. For van der Waals interactions, the cutoff scheme 
with a cutoff of 11 Å was used. The velocity rescaling thermostat 
was used with a reference temperature of T = 300 and 310 K for the 
hGHR-ICD and hGHR-GFP + POPC simulations, respectively, with 
a coupling constant of T = 1 ps. For the equilibrations, the Berendsen 
barostat was used (p = 1 bar, p = 3 ps), whereas the production runs 
were performed with a Parrinello-Rahman barostat (p = 1 bar, p = 12 ps) 
(73). A semi-isotropic pressure coupling was used for the hGHR-
GFP system embedded on a lipid bilayer. For all systems, an initial 
round of equilibrations with decreasing constraints applied to the 
protein beads (hGHR-ICD) and protein beads and lipid beads 
(hGHR-GFP) was performed.
Sampling of the hGHR-ICD simulations with an increase in the 
protein-water interactions of 10, 11, 12, 13, 14, and 15% was en-
hanced using a well-tempered metadynamics (74) protocol applied 
with PLUMED 2.5 (75). The Rg of the protein was used as collective 
variable within the boundaries of 30 to 110 Å. The metadynamics pa-
rameters used were a bias factor of 50, Gaussian height of 4.2 kJ/mol, 
and collective variable space Gaussian widths equal to 0.3.
Analysis of the MD trajectories was performed using plugins and 
analysis tools implemented in VMD, GROMACS, and PLUMED 
together with in-house-prepared tcl and python scripts. All molecular 
renderings were done with VMD.
Fitting of the SAXS data of the hGHR-ECD and hGHR-ICD
Similar protocols were used to fit the SAXS data of the hGHR-ECD 
and hGHR-ICD with the conformations obtained from the modeling 
of hGHR-ECD and MD simulations of hGHR-ICD, respectively: (i) 
For the hGHR-ECD, the SAXS profile of each model was directly 
calculated and fitted to the SAXS data using Pepsi-SAXS (76), with 
all parameters free. For the conformations obtained from different 
hGHR-ICD simulations, an initial round of back-mapping was per-
formed to go from CG to all atoms as described in (58), before cal-
culating and fitting its SAXS profile with Pepsi-SAXS. (ii) From the 
fits, the average value of the hydration shell contrast was calculated 
(hGHR-ECD = 7.4%; hGHR-ICD = 4%) and used as a fixed param-
eter in a second round of fitting. (iii) The average scattering profile 
of the ensemble was calculated directly from the Pepsi-SAXS inten-
sity files and compared to the data. (iv) In the case of hGHR-ECD, 
the BME (31) procedure was used to reweight the ensemble against 
the experimental data. From the reweighted ensemble, a represent-
ative subensemble of 500 conformations was obtained.
Semianalytical model for the ND-embedded hGHR-GFP
To generate the semianalytical model for the full-length hGHR-
GFP, a hybrid approach, which combines analytical approaches to 
describe the nanodisc and the hGHR-ICD with rigid body modeling 
for the ECD-TMD and the GFP, was implemented in the WillItFit 
(48) framework. The mathematical model for hGHR-GFP in nano-
discs, illustrated in Fig. 5A, is composed of four distinct amplitude 
components arising from the ECD-TMD, the ICD, the attached 
GFP, and the surrounding nanodisc. The final expression for the 
total scattering intensity was calculated on the absolute scale as the 
orientationally averaged scattering amplitude squared according to 
standard theory of small-angle scattering
  I(q) = n ∙  ⟨ ∣ A ECD−TMD ( → q ) +  A ICD ( → q ) +  A GFP ( → q ) +  A ND ( → q )∣ 2 ⟩  
where ⟨…⟩ denotes the orientational average, ∣…∣ denotes the 
complex norm, n is the number density of particles, and  A( → q ) is the 
scattering amplitude of each component for a single particle, each 
of which is equipped with a phase factor accounting for its relative 
position in the complex. Subscript ECD-TMD refers to the ECD 
with the TMD, ICD refers to the intrinsically disordered ICD, and 
GFP refers to the green fluorescent protein, which is fused to the 
ICD. ND refers to the surrounding POPC-loaded nanodisc. For each 
amplitude term,  A( → q ) , we furthermore have ensured correct nor-
malization through  A( → q ) =  ∙ V ∙ F( → q ) , where  is the average 
excess scattering length density, V is the molecular volume, and  F( → q ) 
is the normalized form factor amplitude for the relevant compo-
nent. The model for the surrounding nanodisc,  A ND ( → q ) , is the same 
as we have described previously (40): A stack of five elliptical cylin-
ders representing the phospholipid bilayer is surrounded by a 
hollow elliptical cylinder representing the two stacked MSPs. As 
done previously (40), molecular constraints were systematically 
implemented to constrain the nanodisc solution space. As a part of 
this, the height of the MSP was fixed to a value of 25.8 Å, as derived 
from a high-resolution structure of nanodiscs (39), and values for 
the molecular volume () for the POPC lipids were taken from the 
literature (49). The scattering amplitudes of the ECD-TMD and the 
GFP of the hGHR were calculated from their atomic coordinates as 
a part of our WillItFit (48) framework as outlined in previous work 
(26) and incorporated into the ND as rigid bodies. PDB 1EMA was 
used for the GFP atomic coordinates, while those of the flexible 
ECD-TMD were obtained from one of the back-mapped structures 
from one of the (full-length) GHR-GFP + POPCpws10 simulations, 
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but considering only the residues that comprise the SP, ECD, ECD-
TMD linker, and TMD (residues −18 to 270). We used our previ-
ously developed formalism (26) to ensure that the TMD displace 
lipids in the ND and for adjusting the excess scattering lengths of 
the lipid-embedded residues by considering their lipid environ-
ment rather than the solvent (26). To gain computational speed, we 
described the scattering from the ICD as a Gaussian random coil 
where the form factor for the average scattering intensity is readily 
described through the analytical Debye function (38) parameterized 
through the average Rg of the coil. The center of mass of the Gauss-
ian random coil was placed one Rg below the center of the lower 
interface between nanodisc lipid headgroups and solvent. The aver-
aged form factor amplitude for a Gaussian random coil required for 
the off-diagonal cross-terms in the calculation of I(q) in the above 
equation is given by the so-called Hammouda function (77), which 
is also a function of the Rg of the coil. Hence, we used the same 
modeling principle as previously applied for polymer-modified mi-
celles (78) to take into account the scattering contribution from a 
flexible ICD, which is connected to a nanodisc-embedded TMD in 
the model. Following a similar philosophy, the scattering from the 
GFP was randomly oriented and located within a certain allocated 
confusion volume. This way, the model captures the dynamically 
evolving position of the GFP with respect to the rest of the system. 
For the modeling of the shape of the confusion volume, we attempt-
ed to mimic the bowl-like distribution of GFP below the bilayer as 
observed in the CG-MD simulation of hGHR in a lipid bilayer (see 
Fig.  6F) by placing the GFP randomly in a thick cylindrical shell 
below the nanodisc (see Fig. 6A, inner and outer shell radii equal to, 
respectively, 1 and 1.5 times the Rg of hGHR-ICD). However, we 
found that the actual shape of the confusion volume, whether it was 
bowl shaped or simply spherical and centered under the disc, only 
had a minor effect. The WillItFit implementation of the model 
can be downloaded free for use (see Code availability section in 
Acknowledgments).
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/7/27/eabh3805/DC1
View/request a protocol for this paper from Bio-protocol.
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